Detalhe da pesquisa
1.
COVID-19 Therapeutics and Vaccines: A Race to Save Lives.
Toxicol Sci
; 185(2): 119-127, 2022 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735018
2.
An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines.
Toxicol Pathol
; 39(4): 716-44, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21666103
3.
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients.
Hepatol Int
; 15(1): 71-81, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33394321
4.
Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3-Knockin Mice.
Mol Cancer Ther
; 18(11): 2051-2062, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395688
5.
Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice.
Mol Cancer Ther
; 16(5): 861-870, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28265006
6.
Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Cancer Res
; 63(10): 2675-80, 2003 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12750296
7.
14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s).
Cancer Res
; 62(22): 6475-80, 2002 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12438239